Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | GENMAB | 15 | - | -3,83 % | |
| NOVO NORDISK | 14 | 40 | -0,17 % | |
| NKT | 5 | 1 | +0,83 % | |
| FLSMIDTH & CO | 3 | 1 | -0,89 % | |
| VESTAS WIND SYSTEMS | 2 | 9 | -0,38 % | |
| ZEALAND PHARMA | 2 | 1 | +0,73 % | |
| BAVARIAN NORDIC | 1 | 7 | +0,46 % | |
| CARLSBERG | 1 | 3 | -0,45 % | |
| AP MOELLER-MAERSK | - | 23 | +0,34 % | |
| ORSTED | - | 17 | -0,34 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:45 | "Hapag-Lloyd raised to $35, Maersk to $30": Zim Chairman on the intense bidding war that led to the $4.2 billion sale | 1 | CTech | ||
| 10:30 | Novo nordisk verliert an Boden: Experten raten zur Vorsicht | Hebelschein-Spekulant | |||
| 09:15 | NOVO NORDISK A/S - Ruhe als strategische Stärke | 20 | Maximilian Berger | ||
| 08:30 | Novo Nordisk - Nur ein kurzfristiger Bounce nach 30% Rückgang? | 348 | LYNX Broker | Nach dem kräftigen Rückgang steht die Novo-Nordisk-Aktie wieder stärker im Fokus der Anleger. Kurzfristig dürfte vor allem die mögliche Unterstützung im Chart entscheidend se Den vollständigen Artikel... ► Artikel lesen | |
| 08:10 | Bavarian Nordic A/S: Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada | 187 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, February 18, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company's mpox... ► Artikel lesen | |
| 08:06 | Zealand Pharma reports positive Phase 1a results for ZP9830 | 6 | Investing.com | ||
| 07:46 | FLSmidth A/S: FLSmidth 2025 Annual Report: Solid performance provides strong foundation for the next phase, focused on accelerating growth | 162 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO. 13-2026FLSmidth & Co. A/S18 February 2026Copenhagen, Denmark
Today, the Board of Directors of FLSmidth & Co. A/S (FLSmidth) have approved the 2025 Annual Report. In... ► Artikel lesen | |
| 07:36 | Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 | 1 | GlobeNewswire (Europe) | Press release - No. 4 / 2026 Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe adverse... ► Artikel lesen | |
| 05:54 | Genmab GAAP EPS of $15.37, revenue of $3.72B misses by $50M; initiates FY26 outlook | 9 | Seeking Alpha | ||
| 05:06 | FLSmidth A/S: FLSmidth: Transactions under share buy-back programme | 4 | GlobeNewswire (USA) | ||
| Di | Genmab: Q4 Earnings Insights | 4 | Benzinga.com | ||
| Di | Genmab startet Aktienrückkaufprogramm im Wert von bis zu 725 Millionen DKK | 7 | Investing.com Deutsch | ||
| Di | Genmab initiates share buy-back program worth up to 725 million DKK | 5 | Investing.com | ||
| Di | GENMAB A/S - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| Di | Genmab A/S: Genmab Announces Initiation of Share Buy-Back Program | 5 | GlobeNewswire (USA) | ||
| Di | Genmab FY 2025 presentation: 19% revenue growth, pipeline expansion on track | 4 | Investing.com | ||
| Di | Genmab steigert Jahresumsatz 2025 um 19 % - Pipeline-Entwicklung im Plan | 6 | Investing.com Deutsch | ||
| Di | Earnings Call: Genmab verfehlt Gewinnprognose für Q4 2025, Aktie legt dennoch zu | 3 | Investing.com Deutsch | ||
| Di | Genmab Sees FY26 Revenue Of Up To $4.4 Bln | 310 | AFX News | WASHINGTON (dpa-AFX) - Genmab A/S (GMAB) published its 2025 annual report and projected higher revenue for 2026, supported by royalty growth and strong product sales. The biotechnology company... ► Artikel lesen | |
| Di | Genmab A/S Full Year Profit Drops | 286 | AFX News | BRUSSELS (dpa-AFX) - Genmab A/S (GMAB) released earnings for full year that Dropped, from the same period last yearThe company's bottom line totaled $963 million, or $15.37 per share. This compares... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.